* Pulmonx Corp LUNG.OQ LUNG.O is expected to show a rise
in
quarterly revenue when it reports results on February 23.
* The Redwood City California-based company is expected to
report
a 44.9% increase in revenue to $14.243 million from $9.83
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Pulmonx Corp is for
a
loss of 36 cents per share. For the same quarter last year, the
company reported a loss of 27 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Pulmonx
Corp is
$49, about 45.7% above its last closing price of $26.60.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.37 -0.37 -0.28 Beat 24.8
Jun. 30 2021 -0.37 -0.37 -0.34 Beat 8.6
Mar. 31 2021 -0.38 -0.38 -0.34 Beat 10.1
Dec. 31 2020 -0.28 -0.28 -0.27 Beat 2.9
Sep. -4.32 -4.32 -2.26 Beat 47.7
30 2020
This summary was machine generated February 22 at 03:01 GMT.
All figures in US dollars unless otherwise stated